Loading…
Alpha Cognition Inc. Common Stock is projected to rise to $10.38 by 2027, a +23% move from its current price of $8.41. ACOG is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $8.17 | $8.42 | $8.67 | +0.08% |
| Jul 14 | $8.08 | $8.42 | $8.78 | +0.15% |
| Jul 15 | $8.01 | $8.43 | $8.87 | +0.23% |
| Jul 16 | $7.95 | $8.44 | $8.95 | +0.30% |
| Jul 17 | $7.90 | $8.44 | $9.02 | +0.38% |
| Jul 18 | $7.86 | $8.45 | $9.08 | +0.46% |
| Jul 19 | $7.82 | $8.45 | $9.14 | +0.53% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.82 | $8.45 | $9.14 | +0.53% |
| Week 2 | $7.61 | $8.50 | $9.49 | +1.07% |
| Week 3 | $7.47 | $8.54 | $9.78 | +1.60% |
| Week 4 | $7.35 | $8.59 | $10.04 | +2.14% |
| Week 5 | $7.25 | $8.64 | $10.28 | +2.69% |
| Week 6 | $7.17 | $8.68 | $10.51 | +3.23% |
| Week 7 | $7.10 | $8.73 | $10.73 | +3.78% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Alpha Cognition Inc.
was founded in 2000 and is headquartered in Grapevine, Texas.
Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy.
Alpha Cognition Inc. (ACOG) is a biopharmaceutical company focused on neurodegenerative diseases. The stock trades at $8.50 per share with a market cap of $185.08M and a rank of 3867.
The forecast shows an upward price outlook across the coming years, starting with the 2026 values of min $4.50, avg $8.50, max $11.89 and a Neutral sentiment.
From 2027 onward, the outlook is bullish, with steadily rising averages through 2035 and beyond, culminating in a 2030 average of $19.05 and a long-range path toward substantially higher prices in 2040 and 2050.
A major floor 41.9% below — a decisive break under it would weaken the trend.
The nearest floor, 30.8% below — buyers have tended to step in here.
Price is pressing into resistance (1.3% away) — a breakout level to watch.
A major ceiling 22.3% above — clearing it would confirm fresh momentum.
Key ACOG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACOG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.29 | Buy | $8.25 | Buy |
| MA 10 | $7.76 | Buy | $7.86 | Buy |
| MA 20 | $7.08 | Buy | $7.33 | Buy |
| MA 50 | $6.41 | Buy | $6.71 | Buy |
| MA 100 | $6.23 | Buy | $6.44 | Buy |
| MA 200 | $6.20 | Buy | $6.46 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 78.46 | Sell |
| Stoch RSI (14) | 85.54 | Sell |
| CCI (20) | 115.43 | Buy |
| Williams %R (14) | -5.45 | Info |
| MACD (12,26,9) | 0.17 | Buy |
| ROC (12) | 27.91 | Buy |
| Bollinger %B (20,2) | 0.88 | Neutral |
| Stochastic %K (14) | 94.55 | Sell |
| TRIX (15) | 0.95 | Buy |
| Awesome (5,34) | 1.66 | Buy |
| Ultimate (7,14,28) | 86.06 | Sell |
| Momentum (10) | 1.91 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 8.68 | Sell |
| ADX (14) | 32.52 | Buy |
| ATR (14) | 0.18 | Info |
The 30-day technical picture is bullish. RSI14 sits at 80, while the price sits above both the SMA50 and SMA200, which are $6.33 and $6.19 respectively. Support is $5.73 and resistance is $8.50. The thirty-day range runs from $6.92 to $10.44, and annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.50 | $8.41 | $11.77 | 0% | Neutral | |
| $8.20 | $10.38 | $13.93 | +23% | Bullish | |
| $9.57 | $12.48 | $17.43 | +48% | Bullish | |
| $11.88 | $15.89 | $22.88 | +89% | Bullish | |
| $14.09 | $19.28 | $28.49 | +129% | Bullish | |
| $17.82 | $24.89 | $37.61 | +196% | Bullish | |
| $20.37 | $28.98 | $44.70 | +245% | Bullish | |
| $21.05 | $30.50 | $47.90 | +263% | Bullish | |
| $23.73 | $34.96 | $55.84 | +316% | Bullish | |
| $23.88 | $35.76 | $58.02 | +325% | Bullish | |
| $44.94 | $72.48 | $125.49 | +762% | Bullish | |
| $76.96 | $141.23 | $268.75 | +15.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.50 | $8.41 | $10.50 | +0.00% |
| August 2026 | $7.65 | $9.05 | $11.01 | +7.59% |
| September 2026 | $7.56 | $9.01 | $11.09 | -0.40% |
| October 2026 | $7.70 | $9.24 | $11.49 | +2.57% |
| November 2026 | $7.89 | $9.52 | $11.93 | +2.95% |
| December 2026 | $7.68 | $9.32 | $11.77 | -2.11% |
Click any year to see its month-by-month ACOG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ACOG to range from $4.50 to $11.77 through 2026. The $8.41 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ACOG price prediction for 2027 points to an average of $10.38 (low $8.20, high $13.93) — a potential gain of +23% on today's $8.41. Momentum favours further upside here.
In 2028, ACOG is projected to trade between $9.57 and $17.43, averaging $12.48 — a potential gain of +48% from today's $8.41. That is up +20% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Alpha Cognition Inc. Common Stock's 2029 outlook centres on $15.89, within a $11.88 to $22.88 range. That is up +27% on the projected 2028 average. That marks a +89% change versus current levels. Momentum favours further upside here.
By 2030, ACOG could reach as high as $28.49, with a base case around $19.28 and support toward $14.09 — roughly +129% from $8.41. Buyers look set to stay in control over this stretch.
Expect ACOG to range from $17.82 to $37.61 through 2031. The $24.89 average target implies a +196% move from current prices. That is up +29% on the projected 2030 average. Momentum favours further upside here.
The ACOG price prediction for 2032 points to an average of $28.98 (low $20.37, high $44.70) — a potential gain of +245% on today's $8.41. Buyers look set to stay in control over this stretch.
In 2033, ACOG is projected to trade between $21.05 and $47.90, averaging $30.50 — a potential gain of +263% from today's $8.41. That is up +5% on the projected 2032 average. Momentum favours further upside here.
Alpha Cognition Inc. Common Stock's 2034 outlook centres on $34.96, within a $23.73 to $55.84 range. That is up +15% on the projected 2033 average. That marks a +316% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ACOG could reach as high as $58.02, with a base case around $35.76 and support toward $23.88 — roughly +325% from $8.41. Momentum favours further upside here.
Expect ACOG to range from $44.94 to $125.49 through 2040. The $72.48 average target implies a +762% move from current prices. That is up +103% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ACOG price prediction for 2050 points to an average of $141.23 (low $76.96, high $268.75) — a potential gain of +15.8x on today's $8.41. Momentum favours further upside here.
Investing $1,000 in ACOG today (≈ 118.906064 ACOG) could be worth
$16,792.55
+$15,792.55 (+1579%) by 2050 · US Dollar
Based on the average projected ACOG price of $141.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACOGwould be worth at today's price.
$1,000 invested in ACOG on Jul 10, 2025 (≈ 90.909091 ACOG) would be worth
$764.55
-$235.45 (-23.5%) today · 0.76× · US Dollar
Based on a ACOG entry price of $11 vs. today's $8.41.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.89 | $1,065.91 | +6.6% |
| 1 month ago | $5.99 | $1,404.01 | +40.4% |
| 3 months ago | $6.03 | $1,394.69 | +39.5% |
| 6 months ago | $6.09 | $1,380.95 | +38.1% |
| 1 year ago | $11 | $764.55 | -23.5% |
| All time (1.7y) ago | $5.7 | $1,475.44 | +47.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACOG forecast.
Our base-case forecast reaches $17.00 around 2030.
Implied market cap at $17.00: $370.16M
The multi-year forecast shows a bullish trend with rising averages across many years. In 2026 the min price is $4.50, the avg is $8.50, and the max is $11.89, with an overall sentiment of Neutral. The trajectory continues with 2027 min $8.14, avg $10.37, max $14.03 and ROI 22, followed by 2028 min $9.42, avg $12.39, max $17.48 and ROI 45.8, and 2029 min $11.61, avg $15.69, max $22.85 and ROI 84.5.
The 2030 forecast shows min $13.77, avg $19.05, max $28.51 and ROI 124.1, with bullish sentiment. Through 2031–2035 the averages rise further (2031 $24.63, 2032 $28.58, 2033 $29.92, 2034 $34.14, 2035 $34.56) while maintaining bullish sentiment. In 2040 the forecast hits avg $70.40 and max $124.25 with ROI 728.2, and by 2050 the avg reaches $134.10 with max $261.02 and ROI 1477.6.
These are estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $19.05, with a min of $13.77 and a max of $28.51; the ROI is 124.1% and sentiment is BULLISH.
Forecasts show bullish sentiment from 2027 onward, with rising averages and positive ROIs (e.g., 22% in 2027, up to 1477.6% by 2050). These are estimates and not guarantees.
Yes. The 2030 forecast has an avg of $19.05 and a max of $28.51, so reaching $20 is within the forecast range.
Current price is $8.50 and market cap is $185.08M.
RSI14 is 80, SMA50 is $6.33, SMA200 is $6.19, with support at $5.73 and resistance at $8.50. The 30-day range is $6.92 to $10.44, and annualized volatility is 60%.
Alpha Cognition Inc. Common Stock Community Discussion
0Share your Alpha Cognition Inc. Common Stock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.